Search Results 1201-1210 of 17705 for Fibromyalgia

1. A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) - Mayo Clinic

   A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor ...

2. Reversing the trajectory of life - Mayo Clinic

   Mr. Ma was misdiagnosed at home and experienced a few unsuccessful treatments. His daughter brought Mr. Ma to Mayo Clinic where the patient's rare and ...

3. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   This study will primarily evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded Treatment ...

4. Influenza and Other Emerging Diseases Registry - Mayo Clinic

   About this study. The purpose of this surveillance registry is to characterize the demographics, clinical features, outcomes, and resource utilization of ...

5. In Clinical Trials - Mayo Clinic Research

   The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...

6. A Study to Evaluate the Effectiveness of Using the Heated Eye Pad and Scorpion-1 Touch on Meibomian Gland Dysfunction - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. Trigeminal neuralgia - Doctors and departments - Mayo Clinic

   Learn about this nerve condition that can jolt areas on the face with electric-shock-like pain.

8. Breast cancer - Doctors and departments - Mayo Clinic

   Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

9. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

10. Expanded Access Program (EAP): Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...